![Neo-adjuvant doxorubicin and cyclophosphamide followed by paclitaxel in triple-negative breast cancer amongBRCA1mutation carriers and non-carriers]()
Neo-adjuvant doxorubicin and cyclophosphamide followed by paclitaxel in triple-negative breast cancer amongBRCA1mutation carriers and non-carriersPaluch-Shimon, Shani; Friedman, Eitan; Berger, Raanan; Papa, Moshe; Dadiani, Maya; Friedman, Neil; Shabtai, Moshe; Zippel, Dov; Gutman, Mordechai; Golan, Talia; Yosepovich, Ady; Catane, Raphael; Modiano, Tami; Kaufman, Bella · Breast Cancer Research and Treatment · 2016